Articles tagged with Drug Addiction
The prevalence of methamphetamine-associated heart failure is rising worldwide, affecting a wide range of socio-economic and racial groups. Meth users are more likely to develop severe disease, with longer hospital stays and readmissions, compared to non-users.
A researcher at Ohio University is using a $1.4 million grant from the National Institute on Drug Abuse to develop a training program for healthcare professionals to overcome stigma surrounding Buprenorphine prescriptions. The study aims to increase access to harm reduction services in rural areas.
Research at Aston University found a significant link between childhood deprivation and impulsive behavior, leading to addictions and unhealthy choices later in life. The study showed that children from deprived areas had a higher discount rate, indicating a preference for immediate gratification.
A large registry-based study found lisdexamfetamine to be associated with the lowest risk of hospitalisation and death in people with amphetamine addiction. The medication showed a significant reduction in hospitalisation due to substance use disorder and any cause or death, while benzodiazepine and antidepressant use were linked to po...
A telemedicine program for opioid use disorder patients showed that 55% of patients continued with their medication 30 days after being prescribed buprenorphine. The program received 371 calls and provided 249 buprenorphine prescriptions, filling a significant gap in treatment for this population.
Researchers believe that changes in the brain's orexin system promote drug-seeking behavior and that existing insomnia treatments could reduce or eliminate cravings. Studies have shown that blocking this system reverses addiction in animals and reduces opioid cravings in human subjects.
Research reveals that common gut bacteria enhance cocaine effects in mice by consuming glycine, leading to behavior abnormalities. Supplementing glycine or using a genetically modified bacteria reduces response to cocaine, demonstrating its role as an addiction mediator.
Research reveals that pregnant smokers decrease their daily cigarette count by an average of one cigarette per day before realizing they are pregnant. This trend continues in the month following pregnancy recognition, with a decline from nine to five cigarettes per day on average.
A study found that nicotine from a single cigarette reduces estrogen production in women's brains, which may explain their greater resistance to quitting smoking. The effect was observed in the thalamus, part of the limbic system involved in behavioral responses.
A Washington State University pilot study showed that home sensors can accurately monitor overnight restlessness and sleep problems in people recovering from opioid use disorder. The sensors matched other monitoring methods about 89% of the time, validating patients' concerns about their disturbed sleep.
A team of researchers identified a protein kinase substrate downstream of the dopamine signaling pathway regulating brain reward behavior. The study found that phosphorylation of potassium voltage-gated channel subfamily Q member 2 (KCNQ2) decreases its channel activity, increasing neuronal excitability and promoting reward behavior.
A new European study confirms that banning menthol cigarettes leads to increased smoking cessation rates, with 26.1% of menthol smokers quitting compared to 14.1% of non-menthol smokers. The study also finds that a proposed US ban on menthol cigarettes could lead to over 1.3 million quitters.
Researchers at UC Davis aim to develop monoclonal antibodies that can bind to specific ion channels in nerve cells, inhibiting pain signal transmission. The goal is to create a monthly, non-addictive pain medication to replace opioids, which can lead to addiction.
The Regional Transition Navigator program aims to connect youth and young adults aged 14-25 with needed resources, emphasizing those at risk of homelessness, human trafficking or substance use disorders. The program's long-term goal is to teach problem-solving skills and provide support for a healthier transition into adulthood.
A study found that expanded telehealth services for opioid use disorder care during the COVID-19 pandemic led to individuals staying in treatment longer and reducing their risk of medically treated overdose. The expansion also showed improved receipt and retention of medication-assisted treatment, suggesting a valuable approach to addr...
Mandated PDMP use in US states reduced opioid prescriptions by 6.1% but led to a 50.1% increase in heroin-related deaths, according to researchers from the University of Texas at Dallas.
A new study from the University of Georgia found that four out of five counties with the highest opioid overdose death rates do not have a methadone clinic accessible within a 15-minute drive. Federally qualified health centers (FQHCs) may offer a possible solution to improving access to opioid treatment programs in rural communities.
A new study reveals that methamphetamine use is widespread in rural America, driving overdoses and deaths. The research found that people using both methamphetamine and opioids had a significantly higher risk of nonfatal overdose, with 22% reporting an overdose in the past six months.
Researchers at Tufts University School of Medicine suggest improvements to the release process and treatment for individuals with opioid use disorder (MOUD) who are transitioning from jail to the community. The study identifies three critical areas for improvement: bridge doses, better communication, and phone access.
Researchers mapped out the brain network responsible for nicotine's negative consequences, opening the door to interventions that boost aversive effects to help people quit smoking. The discovery suggests that manipulating this network could treat nicotine dependence by inducing an acute aversive effect.
A clinical trial found that three smoking cessation treatments could also reduce alcohol consumption and found high rates of behavior change for both. Nicotine replacement therapy performed as well as prescription drugs in reducing alcohol intake.
A recent study from the University of Geneva suggests that ketamine's therapeutic use may be safe due to its limited impact on dopamine levels and neuronal communication. The research found that ketamine triggers a short increase in dopamine, but also inhibits a specific receptor that prevents addiction progression.
A new study by Northwestern University predicts a worsening wave of opioid overdoses globally, with no geographic distinction between rural and urban areas. The lethal combination of synthetic opioids and stimulants like cocaine and methamphetamines will be particularly deadly.
A new study shows that telehealth, particularly audio-only visits, helped keep VA patients on medication for opioid use disorder during the pandemic. Phone visits also played a key role in reducing dropouts from care.
A systematic review of 20 studies involving almost 120,000 people found that high-potency cannabis use is associated with a higher risk of addiction and mental health problems, including psychotic disorders. The study suggests that reducing the potency of cannabis products could help minimize these harms.
Price E. Dickson, Ph.D., received a $407,000 NIH grant to investigate the genetic mechanisms driving social reward and cocaine addiction. The study aims to identify genetic signatures associated with preference for social interactions over addictive drugs.
National data indicate that expanded access to methadone treatment during the COVID-19 pandemic did not lead to increased harms, but rather declined percentage of overdose deaths involving methadone. This evidence supports expanding take-home treatment for opioid use disorder.
A Michigan Medicine study found that people with cerebral palsy and spina bifida are prescribed opioids at a rate up to five times higher than those without the conditions. Chronic pain is the most commonly reported symptom among these individuals, raising concerns over addiction and overdose issues.
Researchers found that progesterone levels can affect smoking cessation success in women. By timing a quit attempt during the low-to-high increase of progesterone, women may be able to achieve higher abstinence rates and reduce withdrawal symptoms.
A new study led by UCL and King's College London researchers found that adolescents are three times more likely to develop a cannabis addiction than adults. However, they do not appear to be at increased risk of subclinical depression or anxiety. In contrast, adult users who become addicted may experience worsening mental health symptoms.
Experts outline a framework for treating cancer pain in patients with opioid use disorder or prescription opioid misuse. The study highlights the need for better integration of addiction treatment in cancer care, particularly prescribing methadone and buprenorphine.
Researchers discovered that blocking certain acetylcholine receptors in the lateral habenula balances reward and aversion, making it harder to resist seeking cocaine. This finding identifies a new role for these receptors as a potential target for treating cocaine use disorder.
A Rutgers study reveals that racial and ethnic minority groups were less likely to obtain prescriptions to treat opioid addiction during the COVID-19 pandemic. This trend is particularly concerning, as minority groups face more barriers to healthcare and are already disproportionately affected by the pandemic.
The COVID-19 pandemic disrupted access to addiction treatment for adolescents and young adults, particularly those with private health insurance. Prescription claims data shows a significant decline in buprenorphine prescriptions among this age group, especially among those with commercial insurance coverage.
Using lesion network mapping, researchers mapped addiction remission to entire brain circuits rather than specific regions, pointing to new targets for treatment. The study found a common brain circuit associated with both nicotine and alcohol addiction, suggesting a potentially therapeutic targetable neural pathway for addiction.
A Mayo Clinic study found that disparities in opioid treatment access persist among women, Black and Hispanic populations. Despite increased access, these groups continue to face systemic barriers, including racism, mistrust of healthcare professionals, and lack of clinicians able to prescribe buprenorphine.
Researchers at Johns Hopkins Medicine discovered a molecular connector, BASP1, that helps cocaine latch on to brain cells, even at low doses. This finding may explain why women are more susceptible to cocaine addiction and could lead to new treatments.
A new preliminary study from the US suggests that aromatherapy can reduce post-surgical opioid use by half in patients with anxiety before their operation. The study found that levels of anxiety, depression, and catastrophising were reduced in the aromatherapy group, resulting in lower opioid consumption.
Researchers found that young people aged 12-20 were more likely to become cannabis users in states with legalized recreational use compared to those without. The study also documented an increased likelihood of cannabis use among adults in these states.
A landmark research article published in Science predicted exponential growth in US drug overdose deaths, which has now come true with over 100,000 annual deaths. The Pitt team suggests that a systems analysis and computational models are necessary to understand the deep causal drivers of the epidemic.
Early treatment with psychotropic medications in children and adolescents significantly reduces the risk of developing a substance use disorder (SUD) by 30-35% for ADHD and major depressive disorder. Longer treatment durations also show positive results, especially when initiated before age nine.
A study published in Nature Communications sheds light on dopamine transporter (DAT) function, which regulates brain reward centre communication. The researchers discovered DAT depends on potassium, not just sodium, rewriting textbooks on its mechanism.
The OHSU clinic, which provides same-day access to buprenorphine, has successfully served patients in 32 of Oregon's 36 counties. A new study found that many patients prefer the virtual model, with 12 out of 19 participants expressing strong support for its ease of access and critical role in treatment.
A Rutgers study found that individuals with opioid-use disorder who used non-prescribed buprenorphine before entering treatment were twice as likely to remain in care. Those who used the medication also had significantly lower rates of opioid use during the first six months in treatment.
A Scripps Research study found that environmental cues learned during withdrawal are more powerful than those learned during the early phases of alcohol use, leading to more irresistible cravings. This discovery could lead to new treatments to minimize cravings in people with addictions.
A new study found that the COVID-19 pandemic exacerbated mental health issues and changed drug use behaviors in rural Illinois residents, leading to a higher risk of overdose. The study suggests that structural and community factors during the pandemic increased anxiety, depression, and loneliness, and altered drug use patterns.
A new study by Yale University researchers found that medication treatment services are often not located in the most vulnerable communities, leaving them at risk of disrupted access to treatment during disasters. The study suggests that preparedness for natural disasters should prioritize those placed at highest risk.
A decision-support framework was developed by management science researchers to help clinicians make informed decisions about opioid prescribing. The framework incorporates multiple factors, including recovery time, pain intensity, and patient history, to provide a quantitative model of the prescribing process.
Adolescent drug overdose deaths nearly doubled in 2020 and rose another 20% in early 2021 compared to the 10 years prior, despite stable drug use rates. The increase is largely attributed to illicit fentanyls found in counterfeit pills, which can be deadly if ingested.
A Norwegian University of Science and Technology-developed nasal spray has been tested on over 200 acute overdose patients, restoring breathing in 80% of cases within 10 minutes. The study's findings suggest the nasal spray provides enough antidote for patients to breathe on their own while minimizing the risk of triggering abstinence.
A new study by NIH-funded researchers shows that adolescents with severe substance use disorder symptoms are more likely to develop prescription drug misuse and overdose risks in adulthood. Screening for substance use disorder in teens may help predict adult problems and prevent overdoses.
A new Johns Hopkins study examines the link between psychedelics and consciousness, revealing a significant increase in attributing consciousness to various entities following a psychedelic experience. The study found that participants who reported belief-changing experiences showed substantial increases in attributing consciousness to...
A new study from the University of Copenhagen suggests that the poison from the sea snail species Conus rolani can function as a painkiller, blocking out pain in mice for an even longer time than morphine. This discovery offers a potential alternative to addictive painkillers like morphine and opioids.
Researchers urge federal intervention to make naloxone widely available, citing a 30% increase in fatal overdoses from 2019 to 2020. The lack of accessible distribution points and high costs are major barriers to access, with one prescription dispensed for every 70 high-dose opioid prescriptions nationwide.
A study found that fewer than one-third of patients who fill buprenorphine prescriptions written by emergency physicians subsequently fill prescriptions from other clinicians. Researchers emphasize the need for improved systems to seamlessly transition patients from emergency settings to community treatment providers.
Researchers at Massachusetts General Hospital found that medical marijuana users were more likely to develop cannabis use disorder (CUD) than expected, particularly those seeking relief from anxiety and depression. The study suggests that the current system of dispensing and using medical marijuana may be contributing to this issue.
Researchers found that disruption of normal neuronal functions affects metabolic activity, potentially contributing to drug-seeking behaviors. The study suggests that alterations in dopamine signaling may reprogram the circadian liver metabolome, leading to substance use disorders.
The US overdose death rate exceeded the white rate for the first time in 20 years, driven by synthetic opioids and highly toxic drugs. Black Americans and Native Americans had the highest overdose death rates, highlighting deep-seated inequalities in access to treatment and services.
A new study suggests that outpatient treatment for infective endocarditis can reduce mortality rates, extend life expectancy, and be more cost-effective than standard inpatient therapy. The strategy also showed improved cure rates compared to other approaches.
LaTrice Montgomery, a University of Cincinnati researcher, emphasizes the need for more specific data on cannabis use among different racial and ethnic groups. Her research focuses on cannabis addiction, also known as cannabis use disorder (CUD), which is listed in industry standard handbooks alongside other stimulants.